The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01108120
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01108120
-
- Other papers using this trial's data
- Continuous intrafemoral artery infusion of urokinase improves diabetic foot ulcers healing and decreases cardiovascular events in a long-term follow-up study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01108120. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2022-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
- Condition
- Diabetic Foot Ulcer
- Intervention (Drug)
- continuous intra-femoral thrombolysis group
- Intervention (Drug)
- Conventional therapy group
- Lead sponsor
- Xiang Guang-da
Record details
- Record id
cardio:ct-nct01108120- Content hash
b8fe614569863b864e774b04f5ee4706bf0428d17830cb942753495ff7cc8552